as of may 20, 2015 presented by david green, ph.d., dabcc (cc&tc), facb for alere toxicology...

25
As of May 20, 2015 Presented by David Green, Ph.D., DABCC (CC&TC), FACB Drug Testing Updates

Upload: estella-strickland

Post on 22-Dec-2015

221 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: As of May 20, 2015 Presented by David Green, Ph.D., DABCC (CC&TC), FACB for Alere Toxicology Service, Inc. Drug Testing Updates

As of May 20, 2015

Presented by David Green, Ph.D., DABCC (CC&TC), FACB for Alere Toxicology Service, Inc.

Drug Testing Updates

Page 2: As of May 20, 2015 Presented by David Green, Ph.D., DABCC (CC&TC), FACB for Alere Toxicology Service, Inc. Drug Testing Updates

2

Overview of Drug Testing Process

Page 3: As of May 20, 2015 Presented by David Green, Ph.D., DABCC (CC&TC), FACB for Alere Toxicology Service, Inc. Drug Testing Updates

3

Collection

Accessioning

Screening

Result?

Confirmation Review

Reporting

Data Entry

Drug Testing Process

NegativeNon-Negative

Page 4: As of May 20, 2015 Presented by David Green, Ph.D., DABCC (CC&TC), FACB for Alere Toxicology Service, Inc. Drug Testing Updates

4

Screening

• Highly automated• Uses antibodies to detect a drug

class• Specificity varies• Adequate sensitivity• Used to eliminate negative

specimens

Page 5: As of May 20, 2015 Presented by David Green, Ph.D., DABCC (CC&TC), FACB for Alere Toxicology Service, Inc. Drug Testing Updates

5

Confirmation

• Very Specific• Very Sensitive• Little Automation• Usually designed to detect

single chemical compounds

Page 6: As of May 20, 2015 Presented by David Green, Ph.D., DABCC (CC&TC), FACB for Alere Toxicology Service, Inc. Drug Testing Updates

6

New vs. Residual Use Case Study - THC

• Positive test results separated by one month or more normally indicate new use. The exception is long-term, chronic use.

• All results should be normalized to the measurement of ngTHC/mgCreatinine

• A ratio of 1.5 or greater between sequential positive test results separated by a week or more indicates new use.

• This has a degree of certainty of 95% or greater.

• The longer the period between testing, the higher the degree of certainty.

Formula

ng Drug

mg Creatinine

X 100

Page 7: As of May 20, 2015 Presented by David Green, Ph.D., DABCC (CC&TC), FACB for Alere Toxicology Service, Inc. Drug Testing Updates

7

THCA ng/mL Creatinine mg/dL ngTHCA/mgCreatinine0

100

200

300

400

500

600

389

152

255

188

55

341

118

24.4

483

Day 1 Day 8 Day 14

New vs. Residual Use Case Study - THC

Page 8: As of May 20, 2015 Presented by David Green, Ph.D., DABCC (CC&TC), FACB for Alere Toxicology Service, Inc. Drug Testing Updates

8

Federally Regulated Drug Testing

Page 9: As of May 20, 2015 Presented by David Green, Ph.D., DABCC (CC&TC), FACB for Alere Toxicology Service, Inc. Drug Testing Updates

9

Federally Regulated Testing Panels

Drug Screen (ng/mL)

Confirm (ng/mL)

Amphetamines (AMPHS)

1000 500

Cocaine metabolite (BE)

300 150

Opiates (OPA)

2000 2000

Phencyclidine (PCP)

25 25

Marijuana metabolite (THC)

50 15

Prior to September 30, 2010 Effective October 1, 2010

Drug Screen (ng/mL)

Confirm (ng/mL)

Extended Amphetamines (AMPHEX)*

500 250

Cocaine metabolite (BE)

150 100

Opiates (OPA)

2000 2000

6AM 10.0 10.0

Phencyclidine (PCP)

25 25

Marijuana metabolite (THC)

50 15

*includes MDMA, MDA, & MDEA

Page 10: As of May 20, 2015 Presented by David Green, Ph.D., DABCC (CC&TC), FACB for Alere Toxicology Service, Inc. Drug Testing Updates

10

Regulated Updates on the Horizon

• Oral Fluid Testing• Expanded Opiate test panels to

include Synthetic Opiates• New proposal published May 15,

2015 Comments due 60 days.

Page 11: As of May 20, 2015 Presented by David Green, Ph.D., DABCC (CC&TC), FACB for Alere Toxicology Service, Inc. Drug Testing Updates

11

Opiate Testing

Page 12: As of May 20, 2015 Presented by David Green, Ph.D., DABCC (CC&TC), FACB for Alere Toxicology Service, Inc. Drug Testing Updates

12

• HHS only allows for Morphine & Codeine confirmation.• Screen vs. Confirmation (2009 data)

• 346,990 regulated specimens tested• 3,141 regulated specimens screening positive for an opiate• 430 regulated specimens confirmed positive for an opiate

Federally Regulated Opiate Testing

Codeine Only Morphine Only Codeine & Morphine

Codeine, Morphine, &

6-AM

Morphine & 6-AM

0

50

100

150

200

250

124

236

50

218

Number of Confirmed Opiate Positive Specimens

Page 13: As of May 20, 2015 Presented by David Green, Ph.D., DABCC (CC&TC), FACB for Alere Toxicology Service, Inc. Drug Testing Updates

13

43%

13%

15%

15%

15%

Hydrocodone Oxycodone HydromorphoneOxymorphone Codeine/Morphine

Construction Industry Breakdown of Opiate Positives

Page 14: As of May 20, 2015 Presented by David Green, Ph.D., DABCC (CC&TC), FACB for Alere Toxicology Service, Inc. Drug Testing Updates

14

Metabolism of Opiates

Heroin

6-AM

Morphine

Codeine

Hydrocodone

Hydromorphon

e

Dihydrocodein

e

Oxycodone

Oxymorphone

Page 15: As of May 20, 2015 Presented by David Green, Ph.D., DABCC (CC&TC), FACB for Alere Toxicology Service, Inc. Drug Testing Updates

15

Considerations When Using Expanded Opiate Testing

• Increased positives detected by the Laboratory

• Hydrocodone• Oxycodone

• Most likely covered by legal prescription

• What does the MRO do?• Overturn lab positive• Notify employer for safety

sensitive issues

Page 16: As of May 20, 2015 Presented by David Green, Ph.D., DABCC (CC&TC), FACB for Alere Toxicology Service, Inc. Drug Testing Updates

16

Synthetic Marijuana / Designer Drugs

Page 17: As of May 20, 2015 Presented by David Green, Ph.D., DABCC (CC&TC), FACB for Alere Toxicology Service, Inc. Drug Testing Updates

17

Synthetic Marijuana

• Psychoactive research chemicals sprayed on herbal mixtures

• Mimic the effect of THC, the active ingredient of cannabis

• Found to be 4 to 100 times stronger than marijuana

• Deceptively marketed as incense or herbal smoke products since early 2000s

• Available via the internet and in head shops and convenience stores

• Sold under names such as K2, K3 Legal, Spice, Syn, Haze, and Cloud Nine

• Smoked by wrapping it in joints, smoking it in pipes, or inhaling fumes via vaporizers

Page 18: As of May 20, 2015 Presented by David Green, Ph.D., DABCC (CC&TC), FACB for Alere Toxicology Service, Inc. Drug Testing Updates

18

Synthetic Marijuana Effects

• Not regulated by FDA, “not approved for human consumption.”

• Immediate onset• Short effect time of 30 minutes• Similar impairment issues as

marijuana• Dangers

• Agitation → Psychosis • Rapid heart rate → Heart attack• Confusion• Dizziness • Nausea → Vomitting• Convulsions • Overdose

• John W. Huffman (who first synthesized these – “JWH”): “People who use it are idiots.”1

2009 20100

10002000300040005000600070008000

2,906

6,959

Year to year number of calls to poison centers about exposures to synthetic marijuana 2 • Annual increase of 140%• As of February 29, 2012 = 622,

46% increase over February 2011

1. http://www.msnbc.msn.com/id/354441582. Data from American Association of Poison Control Centers

Page 19: As of May 20, 2015 Presented by David Green, Ph.D., DABCC (CC&TC), FACB for Alere Toxicology Service, Inc. Drug Testing Updates

19

• Potential active ingredients include:• JWH-05• JWH-018• JWH-019• JWH-073• JWH-049• JWH-081• JWH-175• JWH-199• JWH-200• JWH-250• JWH-398• Delta-9-THC• HU-210• CP-55940• CP-47497-C7• CP-47497-C8

• WIN-55212-2• WIN-55212-3• JWH-253/306• JWH-362/246• JWH-007/019• Nabilone• Analogues – V, VII, VIII, and XVI

Synthetic Marijuana’s Legality

• Chemists are constantly changing the formulations.

• The DEA has listed 5 highlighted substances as Schedule 1.

Page 20: As of May 20, 2015 Presented by David Green, Ph.D., DABCC (CC&TC), FACB for Alere Toxicology Service, Inc. Drug Testing Updates

20

Designer Drugs

• Stimulant like amphetamine or hallucinogen like PCP

• Describes drugs which are created (or marketed if they had already existed) to get around existing drug laws

• Early 2000s, explosion in designer drugs being sold over the Internet

• “Research Chemicals” – selling the chemicals for "scientific research" rather than human consumption to avoid the intent clause of the U.S. drug laws

Page 21: As of May 20, 2015 Presented by David Green, Ph.D., DABCC (CC&TC), FACB for Alere Toxicology Service, Inc. Drug Testing Updates

21

Designer Drugs

• Forms of use:• Snorted• Smoked• Taken orally

• Cost: $4 to $20 per pack• Can be purchased at:

• Corner stores• Truck stop• Head shops• Internet

• Some common names:• Black Rob • Blue Silk• Bolivian Bath • Cloud 9• Down2Earth • Energizing Aromatherapy• Hurricane Charlie • Ivory Wave• Kamikaze • Maddie • Ocean Burst • Purple Wave• Red Dove • Super Coke• Vanilla Sky • White Horse

Page 22: As of May 20, 2015 Presented by David Green, Ph.D., DABCC (CC&TC), FACB for Alere Toxicology Service, Inc. Drug Testing Updates

Cathinone

22

Page 23: As of May 20, 2015 Presented by David Green, Ph.D., DABCC (CC&TC), FACB for Alere Toxicology Service, Inc. Drug Testing Updates

23

Designer Drug Effects

• Not regulated by FDA, “not approved for human consumption. “

• Insomnia • Teeth grinding• Agitation → Psychosis • Paranoia → Suicide• Rapid heart rate → Heart attack• Nausea → Vomiting• Seizures• Kidney Failure• Death

2009 20100

1000

2000

3000

4000

5000

6000

7000

304

6,138

Year to year number of calls to poison centers about exposures to synthetic marijuana 2 • Annual increase of nearly 2,000%• As of February 29, 2012 = 229,

52% decrease over February 2011

1. Data from American Association of Poison Control Centers

Page 24: As of May 20, 2015 Presented by David Green, Ph.D., DABCC (CC&TC), FACB for Alere Toxicology Service, Inc. Drug Testing Updates

24

• Includes:• Cathinones – 43 compounds created by modifying the molecular structure

• MDPV – “Bath Salts,” stimulant & euphoric effects for 3 to 8 hours• Mephedrone – “Plant Food,” stimulant & euphoric effects for 30 minutes to 3 hours• Methylone – “Room Odorizer”

• Piperazines – (BZP, TFMPP, mCPP)* stimulant & euphoric effects for 4 to 6 hours• Phenethylamine – “Bromo-DragonFLY,” hallucinatory effects for 12 to 24 hours

• The DEA listed 3 highlighted substances as Schedule 1 (October 2011)• “Except as authorized by law, this action makes possessing and selling these chemicals, or the products

that contain them, illegal in the United States … The temporary scheduling action will remain in effect for at least one year while the DEA and the United States Department of Health and Human Services (DHHS) further study whether these chemicals should be permanently controlled.”

• http://www.justice.gov/dea/pubs/pressrel/pr102111.html

• Other Federal Legislation includes• Federal House Bill HR1254• Federal Senate Bill S409

• State Legislation (as of 2/29/2012)• 22 States with current legislation• 12 States with proposed legislation• 3 States awaiting enactment of legislation

*DEA listed BZP and TFMPP as Schedule 1 on March 18, 2004.

Designer Drugs’ Legality

Page 25: As of May 20, 2015 Presented by David Green, Ph.D., DABCC (CC&TC), FACB for Alere Toxicology Service, Inc. Drug Testing Updates

Thank you. Questions?

aleretoxicology.com

David Green, Ph.D., DABCC (CC&TC), FACB

800.433.3823 #68237

504.934.8237

[email protected]